Other studies26,27 on premenopausal tumors have shown difference in tumor variables such as increased tumor size, lymph node metastasis, ER, PR and Ki67 expression and decreased HER2 and p53 expression compared to postmenopausal tumors. Here, ERBB2 is linked to neoplasm.